Preventing coronary heart disease: high baseline risk strategy and cost effectiveness of guidelines

D Graham Mackenzie, John Forbes, Sarah Wild, Philip Rutledge

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)793
JournalBritish Medical Journal (BMJ)
Volume332
Issue number7544
DOIs
Publication statusPublished - 1 Apr 2006

Keywords

  • Adult
  • Aged
  • Coronary Disease
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Risk Assessment
  • Risk Factors

Cite this